Anthos Therapeutics, a US-based clinical-stage biotechnology company, announced on Thursday that it has named Drew Young as its new chief commercial officer and head of Patient Experience.
Young has more than 25 years of commercial and general management leadership experience. He has spent the last two plus decades in roles of increasing responsibility in the US, Canada, Australia, and New Zealand, mainly in senior roles at Bristol-Myers Squibb and EMD Serono/Merck KGaA, Darmstadt, Germany.
Young holds a degree in Economics from McGill University in Montreal, Canada, He was also a recipient of the Scarlet Key Award for outstanding student leadership.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer